The first ever trials of a Malaria Vaccine is in the final stage and is expected to protect millions of children against the disease.
When approved by the relevant authorities, the vaccine will be used to immunise against the seven other killer diseases.
The Chairman of the Clinical Trial Partnership, Dr Kweku Poku Asante said though the efficacy level of 30 percent is low, it will help achieve the purpose of which the trial was initiated.
No comments:
Post a Comment